Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife
17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife
20 March 2026
FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma
FDA & EMA
20 March 2026
Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery
ONCOLife
19 March 2026
Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target
ONCOLife
14 March 2026
Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity
ONCOLife
14 March 2026
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife
13 March 2026
Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality
ONCOLife
9 March 2026
Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer
Clinical Trials
11 January 2026
Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer
ONCOLife
8 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials
24 December 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.